...
首页> 外文期刊>Pharmacoepidemiology and drug safety >Evidence for prolonged prescribing of aspirin-clopidogrel combination in Scottish primary care.
【24h】

Evidence for prolonged prescribing of aspirin-clopidogrel combination in Scottish primary care.

机译:苏格兰初级保健中长期开具阿司匹林-氯吡格雷联合用药的证据。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To identify whether patients were prescribed the combination of aspirin-clopidogrel in primary care after the generally recommended 12-month period. METHODS: A population based cross-sectional study using data from 61 general practices (1st April 2003-31st March 2004). RESULTS: 691 patients (0.18% of total population) were prescribed aspirin-clopidogrel in combination. 27.78% of these patients had undergone coronary stenting or angioplasty and 34.30% were prescribed this combination for more than 1 year. 96 (13.9%) patients had a previous history of ischaemic stroke or transient ischaemic attack. CONCLUSIONS: Patients were prescribed the combination of aspirin-clopidogrel beyond the generally accepted 12-month period, which may lead to increased safety and cost concerns.
机译:目的:为了确定在一般推荐的12个月后是否向患者开具阿司匹林-氯吡格雷联用药物用于初级保健。方法:采用基于人群的横断面研究,使用61种常规方法(2003年4月1日至2004年3月31日)的数据。结果:691例患者(占总人口的0.18%)接受了阿司匹林-氯吡格雷联合治疗。这些患者中有27.78%接受了冠状动脉支架置入术或血管成形术,并且34.30%的患者接受了这种联合治疗1年以上。 96(13.9%)位患者曾有缺血性中风或短暂性脑缺血发作史。结论:在一般公认的12个月内,患者被处方使用阿司匹林-氯吡格雷联合治疗,这可能会增加安全性和成本问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号